Neratinib Withdrawn Phase 1 Trials for Healthy Volunteers Treatment

IndicationsStatusPurposePhase
WithdrawnTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00932464Study Evaluating The Effect Of A High-Fat Meal On The Pharmacokinetics Of Neratinib